Karplyak V. Clinical and pathogenetic substantiation of the effectiveness of metabolic therapy in patients with coronary heart disease.

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0414U003108

Thesis Registration Form

0414U003108.pdf

Applicant for

Specialization

  • 14.01.11 - Кардіологія

24-04-2014

Specialized Academic Board

Д 35.600.05

Danylo Halytsky Lviv National Medical University

Essay

The paper is devoted to the study of lipid metabolism, C-reactive protein, blood clotting system and fibrinolysis, heart rate variability in patients with unstable angina and the use of metabolic drug - mexicor. The study involved 132 patients with coronary artery disease. Found that the use of the background mexicor conventional treatment of coronary artery disease contributes to improved results of changes in lipid fractions, CRP and quickly eliminated imbalance in the autonomic system regulation of heart rate compared with patients who were on SMT. Drug with cytoprotective action (mexicor) is recommended for use in patients with coronary artery disease, especially in its acute forms (unstable angina) as to significant positive change lipid spectrum, CRP, and coagulation parameters of HRV and prophylaxis of life-threatening complications, so and to improve the prognosis in general.

Read more

Files

aref.docx

dis.docx

Similar theses

0524U000129

Oksana L. Rekovets

Сlinical and pathogenetic justification of individual diagnostic approaches and treatment programs in resistant arterial hypertension

0523U100016

Maslovskyi Valentyn Iuriyovych

Prognostic value of various clinical and instrumental markers and options for basic therapy to assess the quality of life and the nature of the course of myocardial infarction without elevation of the ST segment

0421U103208

Kovbasniuk Yuriy Vasylovych

Structure and functional myocardial changes and features of plasma hemostasis by patient with atrial fibrillation and different body mass index

0821U101742

Tanska Olha Oleksandrivna

Criteria for Patients to be Put on the Waiting List for Heart Transplantation

0821U101115

Kutia Inna Mykolaivna

Pathogenetic and prognostic value of vascular endothelial growth factor-A in acute myocardial infarction with the ST segment elevation